Ad is loading...
RVPH
Price
$1.13
Change
-$0.09 (-7.44%)
Updated
Nov 15 closing price
126 days until earnings call
TCRT
Price
$2.09
Change
-$0.25 (-10.68%)
Updated
Nov 15 closing price
Ad is loading...

RVPH vs TCRT

Header iconRVPH vs TCRT Comparison
Open Charts RVPH vs TCRTBanner chart's image
Reviva Pharmaceuticals Holdings
Price$1.13
Change-$0.09 (-7.44%)
Volume$966.27K
CapitalizationN/A
Alaunos Therapeutics
Price$2.09
Change-$0.25 (-10.68%)
Volume$22.59K
CapitalizationN/A
RVPH vs TCRT Comparison Chart
Loading...
RVPH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TCRT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
RVPH vs. TCRT commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RVPH is a Sell and TCRT is a StrongSell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (RVPH: $1.13 vs. TCRT: $2.09)
Brand notoriety: RVPH and TCRT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RVPH: 215% vs. TCRT: 109%
Market capitalization -- RVPH: $37.62M vs. TCRT: $3.35M
RVPH [@Biotechnology] is valued at $37.62M. TCRT’s [@Biotechnology] market capitalization is $3.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RVPH’s FA Score shows that 1 FA rating(s) are green whileTCRT’s FA Score has 1 green FA rating(s).

  • RVPH’s FA Score: 1 green, 4 red.
  • TCRT’s FA Score: 1 green, 4 red.
According to our system of comparison, RVPH is a better buy in the long-term than TCRT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RVPH’s TA Score shows that 5 TA indicator(s) are bullish while TCRT’s TA Score has 4 bullish TA indicator(s).

  • RVPH’s TA Score: 5 bullish, 4 bearish.
  • TCRT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RVPH is a better buy in the short-term than TCRT.

Price Growth

RVPH (@Biotechnology) experienced а +22.22% price change this week, while TCRT (@Biotechnology) price change was +5.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

RVPH is expected to report earnings on Mar 24, 2025.

TCRT is expected to report earnings on May 09, 2024.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVPH($37.6M) has a higher market cap than TCRT($3.35M). RVPH (-78.155) and TCRT (-80.292) have similar YTD gains . TCRT has higher annual earnings (EBITDA): -18.21M vs. RVPH (-36.24M). RVPH has more cash in the bank: 6.18M vs. TCRT (2.46M). TCRT has less debt than RVPH: TCRT (0) vs RVPH (208K). TCRT has higher revenues than RVPH: TCRT (7K) vs RVPH (0).
RVPHTCRTRVPH / TCRT
Capitalization37.6M3.35M1,123%
EBITDA-36.24M-18.21M199%
Gain YTD-78.155-80.29297%
P/E RatioN/AN/A-
Revenue07K-
Total Cash6.18M2.46M251%
Total Debt208K0-
FUNDAMENTALS RATINGS
RVPH vs TCRT: Fundamental Ratings
RVPH
TCRT
OUTLOOK RATING
1..100
874
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
26
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
5691
P/E GROWTH RATING
1..100
16100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TCRT's Valuation (26) in the Biotechnology industry is somewhat better than the same rating for RVPH (88) in the null industry. This means that TCRT’s stock grew somewhat faster than RVPH’s over the last 12 months.

TCRT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RVPH (100) in the null industry. This means that TCRT’s stock grew similarly to RVPH’s over the last 12 months.

TCRT's SMR Rating (97) in the Biotechnology industry is in the same range as RVPH (100) in the null industry. This means that TCRT’s stock grew similarly to RVPH’s over the last 12 months.

RVPH's Price Growth Rating (56) in the null industry is somewhat better than the same rating for TCRT (91) in the Biotechnology industry. This means that RVPH’s stock grew somewhat faster than TCRT’s over the last 12 months.

RVPH's P/E Growth Rating (16) in the null industry is significantly better than the same rating for TCRT (100) in the Biotechnology industry. This means that RVPH’s stock grew significantly faster than TCRT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RVPHTCRT
RSI
ODDS (%)
Bullish Trend 3 days ago
70%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 3 days ago
76%
MACD
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 3 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
79%
Bullish Trend 6 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
72%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
RVPH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TCRT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PIII0.230.02
+9.12%
P3 Health Partners
UFCS25.420.39
+1.56%
United Fire Group
LAUR18.510.21
+1.15%
Laureate Education
BXP78.53-0.94
-1.18%
BXP Inc.
INM4.28-0.80
-15.73%
InMed Pharmaceuticals Inc

RVPH and

Correlation & Price change

A.I.dvisor tells us that RVPH and TTNP have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RVPH and TTNP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVPH
1D Price
Change %
RVPH100%
-7.02%
TTNP - RVPH
30%
Poorly correlated
-4.64%
GYRE - RVPH
30%
Poorly correlated
-5.20%
INM - RVPH
27%
Poorly correlated
-15.73%
TCRT - RVPH
24%
Poorly correlated
-10.59%
VACBF - RVPH
24%
Poorly correlated
N/A
More

TCRT and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRT has been loosely correlated with NRBO. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRT jumps, then NRBO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRT
1D Price
Change %
TCRT100%
-10.59%
NRBO - TCRT
50%
Loosely correlated
-7.11%
SNTI - TCRT
47%
Loosely correlated
-7.73%
REVB - TCRT
46%
Loosely correlated
-4.02%
BRTX - TCRT
33%
Loosely correlated
-3.97%
ALNY - TCRT
30%
Poorly correlated
-8.67%
More